Richmond VA 黑色素瘤临床试验
11项针对 黑色素瘤的研究正在 Richmond及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
招募中2 期
- Virginia Cancer Institute, Richmond
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- Virginia Commonwealth University Massey Cancer Center, Richmond
Pan-tumor MRD Study
招募中观察性研究
- Virginia Cancer Institute, Richmond
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
招募中3 期
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- 以及另外 3 项
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- VCU Massey Comprehensive Cancer Center, Richmond
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
招募中1/2 期
- Virginia Commonwealth University, Richmond
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
招募中3 期
- VCU - McGlothlin Medical Education Center, Richmond
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- VCU Massey Cancer Center, Richmond
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
招募中2 期
- Massey Cancer Center, Richmond
其他城市的 黑色素瘤试验
- Houston, TX59 项研究
- New York City, NY38 项研究
- Los Angeles, CA34 项研究
- Nashville, TN32 项研究
- Pittsburgh, PA31 项研究
- Boston, MA25 项研究
- Philadelphia, PA23 项研究
- San Francisco, CA22 项研究
- Atlanta, GA21 项研究
- Columbus, OH21 项研究
- Salt Lake City, UT21 项研究
- Durham, NC21 项研究
Richmond的其他研究
- 乳腺癌26 项研究
- 非小细胞肺癌25 项研究
- 前列腺癌19 项研究
- 心力衰竭16 项研究
- 肺癌14 项研究
- 心血管疾病13 项研究
- 结直肠癌13 项研究
- 脂肪性肝病12 项研究
- 急性髓系白血病12 项研究
- 转移性癌症12 项研究
- 头颈鳞状细胞癌12 项研究
- 肥胖症11 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月1日。每项研究自行设定入选标准,由研究团队决定谁能参与。